RxSight, Inc. (RXST) is an innovative and forward-thinking company operating within the medical devices industry. It emphasizes a personalized approach in ophthalmic treatments, primarily focusing on the manufacture and commercialization of pioneering intraocular lenses for treating vision problems.
The company is best known for its revolutionary product, the RxSight Light Adjustable Lens and Activator (LAL), which holds the distinction of being the world’s first and currently, sole FDA-approved adjustable intraocular lens. This lens treats pre-existing astigmatism and post-operative residual refractive error.
RxSight’s proprietary technology allows surgeons to adjust lens power after cataract surgery, providing patients the opportunity to have their vision customized to their unique specifications post-operatively. This essentially means that they can create personalized vision for patients, dramatically improving their quality of life.
The company also provides the Light Delivery Device (LDD) to activate locked-in final lens prescription adjustments. This eliminates the need for additional surgeries, making the process substantially less invasive for patients.
Founded in 2006 and headquartered in Aliso Viejo, California, RxSight is led by CEO John Kilcoyne. Kilcoyne has a long history in the medical devices arena, bringing vast experience, leadership, and expertise to the helm of the company. Under his leadership, the company aims not only to revolutionize ophthalmic treatment but to set a high standard for personalized medical treatment in other areas as well.
RxSight is committed to improving the lives of individuals living with vision problems by providing next-level care and treatments. The company’s innovation-centric mindset and focus on personalized medicine are key drivers propelling it towards significant growth and success in the competitive field of medical devices.
The company, its experienced team, and their breakthrough product have demonstrated a promising future in the ophthalmic industry. As more healthcare providers become aware of the benefits of RxSight's revolutionaryLight Adjustable Lens, the company is set to change the landscape of eye care for many patients around the world.